Investing
First Look Analysts Research Calls for Thursday, January 26
Published:
This report was sent to Briefing.com subscribers earlier today.
> FibroGen (FGEN) upgraded to Outperform from Mkt Perform at Raymond James; tgt $35
> easyJet (ESYJY) downgraded to Mkt Perform from Outperform at Bernstein
> EVgo Inc. (EVGO) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $6
> Hyatt Hotels (H) downgraded to Equal Weight from Overweight at Wells Fargo; tgt raised to $113
> Lending Club (LC) downgraded to Neutral from Buy at Janney; tgt $10
> Popular (BPOP) downgraded to Mkt Perform from Outperform at Keefe Bruyette; tgt lowered to $74
> Albemarle (ALB) initiated with an Overweight at Piper Sandler; tgt $310
> Datadog (DDOG) initiated with an Overweight at Cantor Fitzgerald; tgt $95
> Dexcom (DXCM) initiated with an Outperform at Wolfe Research; tgt $121
> Dyne Therapeutics (DYN) initiated with a Buy at Guggenheim; tgt $33
> Exelixis (EXEL) initiated with an Outperform at Credit Suisse; tgt $29
> JFrog (FROG) initiated with an Overweight at Cantor Fitzgerald; tgt $29
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.